Cargando…
Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037371/ https://www.ncbi.nlm.nih.gov/pubmed/36961664 http://dx.doi.org/10.1007/s11892-023-01501-7 |
_version_ | 1784911863787552768 |
---|---|
author | Rodriquez, Isabella Marranzini O’Sullivan, Katie L. |
author_facet | Rodriquez, Isabella Marranzini O’Sullivan, Katie L. |
author_sort | Rodriquez, Isabella Marranzini |
collection | PubMed |
description | PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM. RECENT FINDINGS: The incidence of youth-onset T2DM is rising, and significantly accelerated following the COVID-19 pandemic. Youth with T2DM are more frequently from families of racial/ethnic minorities and lower socioeconomic status. Youth-onset T2DM has more rapid disease progression compared to adult-onset type 2 diabetes. It results in earlier and more severe microvascular and macrovascular complications compared to both adult-onset T2DM and youth-onset type 1 diabetes (T1DM). While there is a lack of data describing the socioeconomic cost of youth-onset T2DM, based on extrapolation from analyses of the burden of T2DM in adults and T1DM in youth, we propose that youth-onset T2DM has higher direct and indirect costs than adult-onset T2DM. SUMMARY: Youth-onset T2DM presents a significant clinical and socioeconomic burden due to its aggressive presentation and earlier appearance of complications. Additional research is needed regarding the cost of illness in this population. |
format | Online Article Text |
id | pubmed-10037371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-100373712023-03-24 Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost Rodriquez, Isabella Marranzini O’Sullivan, Katie L. Curr Diab Rep Article PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM. RECENT FINDINGS: The incidence of youth-onset T2DM is rising, and significantly accelerated following the COVID-19 pandemic. Youth with T2DM are more frequently from families of racial/ethnic minorities and lower socioeconomic status. Youth-onset T2DM has more rapid disease progression compared to adult-onset type 2 diabetes. It results in earlier and more severe microvascular and macrovascular complications compared to both adult-onset T2DM and youth-onset type 1 diabetes (T1DM). While there is a lack of data describing the socioeconomic cost of youth-onset T2DM, based on extrapolation from analyses of the burden of T2DM in adults and T1DM in youth, we propose that youth-onset T2DM has higher direct and indirect costs than adult-onset T2DM. SUMMARY: Youth-onset T2DM presents a significant clinical and socioeconomic burden due to its aggressive presentation and earlier appearance of complications. Additional research is needed regarding the cost of illness in this population. Springer US 2023-03-24 2023 /pmc/articles/PMC10037371/ /pubmed/36961664 http://dx.doi.org/10.1007/s11892-023-01501-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Rodriquez, Isabella Marranzini O’Sullivan, Katie L. Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title | Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title_full | Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title_fullStr | Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title_full_unstemmed | Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title_short | Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost |
title_sort | youth-onset type 2 diabetes: burden of complications and socioeconomic cost |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037371/ https://www.ncbi.nlm.nih.gov/pubmed/36961664 http://dx.doi.org/10.1007/s11892-023-01501-7 |
work_keys_str_mv | AT rodriquezisabellamarranzini youthonsettype2diabetesburdenofcomplicationsandsocioeconomiccost AT osullivankatiel youthonsettype2diabetesburdenofcomplicationsandsocioeconomiccost |